Broken String Biosciences closes $15M series A funding round

Broken String Biosciences today announced that it has closed a $15 million Series A investment round.

Novo’s semaglutide shows potential in chronic skin condition in obese patients

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 26, 2024

Protect the health of pregnant people and their children by including them in research

Imagine having to make this decision: Your health care provider recommends that you take a specific medicine for an illness or condition but then tells

April 30, 2024

Verrica receives FDA approval for YCANTH to treat molluscum

Molluscum contagiosum, or water wart. Credit: E van Herk / commons.wikimedia.org. Verrica Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for

July 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.